146 related articles for article (PubMed ID: 111465)
21. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea.
Chan WY
Annu Rev Pharmacol Toxicol; 1983; 23():131-49. PubMed ID: 6347048
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed.
Owen PR
Am J Obstet Gynecol; 1984 Jan; 148(1):96-103. PubMed ID: 6419611
[TBL] [Abstract][Full Text] [Related]
23. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
[TBL] [Abstract][Full Text] [Related]
24. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
Strömberg P; Forsling ML; Akerlund M
Obstet Gynecol; 1981 Aug; 58(2):206-8. PubMed ID: 7254732
[TBL] [Abstract][Full Text] [Related]
25. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
Lalos O; Joelsson I
Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
[TBL] [Abstract][Full Text] [Related]
26. Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women.
Pulkkinen MO; Csapo AI
Prostaglandins; 1979 Jul; 18(1):137-42. PubMed ID: 392621
[TBL] [Abstract][Full Text] [Related]
27. Effects of a vasopressin antagonist in women with dysmenorrhea.
Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
[TBL] [Abstract][Full Text] [Related]
28. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
Chan WY; Fuchs F; Powell AM
Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
[TBL] [Abstract][Full Text] [Related]
29. Effects of suprofen and other prostaglandin synthetase inhibitors in a new animal model for myometrial hyperactivity.
Hahn DW; Carraher R; McGuire JL
Prostaglandins; 1982 Jan; 23(1):1-16. PubMed ID: 6801733
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience.
Jacobson J; Cavalli-Björkman K; Lundström V; Nilsson B; Norbeck M
Acta Obstet Gynecol Scand Suppl; 1979; 87():73-9. PubMed ID: 111467
[TBL] [Abstract][Full Text] [Related]
31. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
Lundström V
Acta Obstet Gynecol Scand; 1977; 56(3):167-72. PubMed ID: 878858
[TBL] [Abstract][Full Text] [Related]
32. [Prostaglandins and dysmenorrhea effect of naproxen on prostaglandin concentrations in menstrual blood (author's transl)].
Ninagawa T; Matsukawa R; Yoshio T; Kan S; Ito K
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):449-54. PubMed ID: 7234342
[TBL] [Abstract][Full Text] [Related]
33. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
[TBL] [Abstract][Full Text] [Related]
34. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea.
Milsom I; Andersch B
Br J Obstet Gynaecol; 1984 Nov; 91(11):1129-35. PubMed ID: 6388624
[TBL] [Abstract][Full Text] [Related]
35. Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.
Lalos O; Nilsson B
Int J Gynaecol Obstet; 1983 Feb; 21(1):33-7. PubMed ID: 6133791
[TBL] [Abstract][Full Text] [Related]
36. The antagonism by anti-inflammatory analgesics of prostaglandin f 2 alpha-induced contractions of human and rabbit myometrium in vitro.
Smith ID; Temple DM; Shearman RP
Prostaglandins; 1975 Jul; 10(1):41-57. PubMed ID: 1153803
[TBL] [Abstract][Full Text] [Related]
37. Dysmenorrhea during adolescence.
Widholm O
Acta Obstet Gynecol Scand Suppl; 1979; 87():61-6. PubMed ID: 288295
[TBL] [Abstract][Full Text] [Related]
38. The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients.
Pulkkinen MO; Csapo AI
Prostaglandins; 1978 Jun; 15(6):1055-62. PubMed ID: 358295
[TBL] [Abstract][Full Text] [Related]
39. Letter: The effect of anti-prostaglandin on the hypertonic saline-induced uterine activity.
Csapo AI; Kaihola HL; Kivikoski A; Pulkinen MO
Prostaglandins; 1975 Apr; 9(4):627-9. PubMed ID: 1098114
[No Abstract] [Full Text] [Related]
40. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
Cockrum RH; Tu FF; Kierzkowska O; Leloudas N; Pottumarthi PV; Hellman KM
Am J Obstet Gynecol; 2024 May; 230(5):553.e1-553.e14. PubMed ID: 38295969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
